About 105,000 results
Open links in new tab
Genentech inks $850M upfront deal for Regor’s CDK inhibitors
Genentech buys Regor's next-gen CDK inhibitors for $850M
Genentech To Acquire Portfolio Of Next-generation CDK Inhibitors …
Regor to Sell Breast Cancer CDK Inhibitors to Roche Unit for …
Roche Doubles Down on Breast Cancer With $850M for Regor’s …
Roche turns to a startup in search for new breast cancer drugs
Genentech to acquire Regor's next-gen CDK inhibitors portfolio
Genentech acquires Regor's CDK inhibitors for breast cancer
Regor Enters into a Definitive Purchase Agreement for Genentech …
Genentech To Acquire Portfolio Of Next-generation CDK Inhibitors …
- Some results have been removed